article · Pharmacopsychiatry
Clozapine is an atypical antipsychotic with proven efficacy in the management of treatment-resistant schizophrenia. It has well-documented side effects, including agranulocytosis, myocarditis, epileptic seizures, and secondary metabolic disturbances. Additionally, it is known to have rare secondary side effects, such as stuttering, which has been documented in several case reports. This case highlights the importance for clinicians to be aware of clozapine-induced stuttering, even in the absence of known risk factors, and emphasizes the necessity for future research to investigate the pathophysiology of clozapine-induced stuttering [1].
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1055/a-2189-5597
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
